ReviewMagma (New York, N.Y.)2026
Recent advances in arterial spin labeling MRI for imaging brain tumors.
Review in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Perfusion MRI plays an important role in brain tumor assessment, especially for tumor grading and differentiation of tumor progression from pseudoprogression. Arterial spin labeling (ASL) MRI is a non-invasive method for measuring cerebral blood flow (CBF) using blood water as an endogenous tracer, which has great clinical potential for brain tumor imaging and might help to lower the use of gadolinium-based contrast agents. In this review, we discuss recent advances of the ASL method with a special focus on brain tumors, including multi-time point ASL which not only allows more accurate CBF quantification, but also yields arterial transit time (ATT) maps. Another method to reduce dependency on ATT is velocity-selective ASL, for which labeling is directly performed in the imaging volume. By performing a physiological challenge, like a hypercapnia breathing challenge, the reactivity of the tumor's neovasculature can be determined. More recent advances in ASL allow probing the blood-brain barrier (BBB) integrity by measuring the rate of water transport across the BBB (BBB-ASL). By labeling only a single artery, selective ASL sequences can help to identify what part of the tumor is fed by which artery. In conclusion, we see the future potential of ASL MRI not only in replacing contrast agents for perfusion assessment but also in providing additional information to the MRI exam, such as BBB integrity or the architecture of the vascular feeders.
Indexed as
Identifiers
42658455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.